The Critical Care Response to the COVID-19 Pandemic in Madrid

COVID-19 Clinical Trial

— Tetrix  

Official title:

The Critical Care Resources Adaptation to the SARS-CoV-2 Pandemic in Madrid

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04393324
• Other study ID #: Madrid COVID Tetrix
• Status: Recruiting
• Start date: April 24, 2020
• Est. completion date: June 30, 2020

Study information

• Verified date: May 2020
• Source: Hospital San Carlos, Madrid
• Contact: Miguel S Sanchez Garcia, MD
• Phone: +34913303223
• Email: miguelsanchez.hcsc[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Description of the adaptation of ICUs in the region of Madrid to que surge in demand of critical care due to COVID-19

Description:

Background

The worldwide SARS-CoV-2 pandemic has put healthcare systems under the extreme pressure, with intensive care units being faced with a previously unseen number of patients with severe respiratory failure requiring admission for endotracheal intubation and mechanical ventilation.

Methods

The study describes how the critical care resources adapted to the sudden surge of severe Covid-19 in the province of Madrid, which developed at the beginning of March 2020. The response consisted of a swift increase in ICU capacity and the relocation of patients. ICU beds were mounted outside the usual intensive care areas. Transfer of critically ill intubated patients with COVID-19 was managed in an instant messenger service group composed of representatives of 53 intensive care units and performed by the Madrid Emergency Medical Systems (EMS). The investigators will compare transferred with non-transferred patients matched for risk factors for cardiovascular and respiratory complications.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2500
• Est. completion date: June 30, 2020
• Est. primary completion date: May 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Admitted to ICU in Madrid with COVID-19

Exclusion Criteria:

• Admitted to ICU without COVID-19

Related Conditions & MeSH terms

• ARDS, Human
• COVID-19
• Respiratory Distress Syndrome, Adult

Locations

Country	Name	City	State
Spain	Hospital Clinico San Carlos	Madrid

Sponsors (2)

Lead Sponsor	Collaborator
Hospital San Carlos, Madrid	Fundación de Investigación Hospital Clínico San Carlos

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality	ICU mortality	9 weeks
Secondary	Length of ICU stay	From admission to discharge or death	9 weeks